Tetsu Kamitani

Years Active: 2022-2022
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Nobuyuki Yamamoto, Tetsu Kamitani, Kingo Kanda, Yuichiro Ito, Masahiro Hamada, Masahiko Ozaki, Noriko Takeuchi, Tomoko Yamada, Masaki Kawano, Shinichiroh Maekawa, Terufumi Kato
Real-world outcomes of pembrolizumab monotherapy in non-small cell lung cancer in Japan: A post-marketing surveillance. Cancer science 113 (9) (2022)
Hiroshi Nokihara, Takashi Kijima, Toshihide Yokoyama, Hiroshi Kagamu, Takuji Suzuki, Masahide Mori, Melissa L Santorelli, Kazuko Taniguchi, Tetsu Kamitani, Masato Irisawa, Kingo Kanda, Machiko Abe, Thomas Burke, Yasushi Goto
Real-World Treatments and Clinical Outcomes in Advanced NSCLC without Actionable Mutations after Introduction of Immunotherapy in Japan. Cancers 14 (12) (2022)

Tetsu Kamitani.css-eqlu8i{font-size:small;padding-left:4px;}